Functional proteomic analysis reveals roles for PKCδ in regulation of cell survival and cell death: Implications for

Jordan T Speidel1, Trisiani Affandi1, David N M Jones2

  • 1Department of Craniofacial Biology, School of Dental Medicine, USA.

Insights

Protein Kinase C-delta (PKCδ) has dual roles in cell death and survival, impacting cancer development. Understanding its context-dependent functions is key for developing targeted cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Protein Kinase C-delta (PKCδ) is implicated in diverse biological processes, including immune function, cell survival, and apoptosis.
  • Genetic disruption of the PRKCD gene in mice demonstrates protective effects in various disease and tissue damage models.
  • PKCδ exhibits context-dependent roles, promoting apoptosis in normal cells but survival/proliferation in some transformed cells and cancer models.

Purpose of the Study:

  • To elucidate the multifaceted biological functions of PKCδ.
  • To explore the potential roles and paradoxical functions of PKCδ in cancer development.
  • To identify PKCδ-dependent pathways using functional proteomics to understand its regulatory mechanisms and signaling plasticity.

Main Methods:

  • Review of existing literature on PKCδ functions.
  • Analysis of genetic disruption models (PRKCD gene in mice).
  • Functional proteomics to identify PKCδ-dependent signaling pathways.

Main Results:

  • PKCδ regulates apoptosis in normal tissues but can promote survival and proliferation in transformed cells.
  • The role of PKCδ in cancer appears dependent on the specific oncogenic context of the tumor.
  • Functional proteomics identified pathways regulated by PKCδ, offering insights into its signaling plasticity.

Conclusions:

  • PKCδ possesses paradoxical roles in cell survival and death, significantly influencing cancer progression.
  • Understanding the context-specific regulation of PKCδ is crucial for designing effective therapeutics targeting this pathway.
  • Further research into PKCδ-dependent pathways will be vital for advancing cancer treatment strategies.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K